Egerton Capital UK's John Armitage Activity in Q3 2026: Key Purchases and Sales

As of September 30, 2026, John Armitage, managing director of Egerton Capital UK, documented significant changes in his investment portfolio. These adjustments reflect strategic decisions across various sectors, with a particular emphasis on Technology and Financial Services holdings.

Notable Purchases

Armitage demonstrated strong buying interest during this quarter, adding substantial positions to three key stocks. He significantly increased his stake in AMPHENOL CORP (APH), raising the position by 120.04% and boosting its portfolio allocation to 9.19%. Similarly, he bolstered S&P GLOBAL INC (SPGI) by increasing shares by 124.59%, now accounting for 3.17% of the portfolio. Additionally, Armitage initiated a new position in VISTRA CORP (VST), adding it to the portfolio at a 1.34% allocation.

Significant Reductions

Conversely, Armitage reduced his exposure in two Communication Services companies. He sold shares of META PLATFORMS INC (META) and THERMO FISHER SCIENTIFIC INC (TMO), both resulting in substantial decreases. The META position saw a 64.36% reduction in shares, lowering its portfolio percentage to 1.42%. Similarly, the TMO position experienced a 64.76% reduction, reducing its allocation to 1.36%. These exits signal a shift away from this sector in his current strategy.

Other Portfolio Changes

Several other holdings also saw changes during the quarter, though not to the same degree as the significant buys and sells. Energy holdings like DEVON ENERGY CORP NEW (DVN) increased by 43.28%, while Technology holdings such as ALPHABET INC (GOOG) saw a significant 36.23% reduction. Other adjustments include a decrease in Healthcare's MEDLINE INC (MDLN) position and changes in Financial Services, Utilities, and Basic Materials allocations.

Overall Portfolio Strategy

The portfolio's structure as of September 30, 2026, shows a continued focus on Technology and Financial Services, which together represent the core of his investment approach. The top five holdings now account for 52.36% of the total portfolio value, indicating a concentrated strategy. For more detailed insights into John Armitage's investment activities, you can explore the full report on Egerton Capital UK". The overall value of the portfolio stands at £1.26 billion, reflecting the substantial size of his investment decisions.